Skip to main content
Daniel Merenstein, MD, Family Medicine, Vienna, VA, MedStar Georgetown University Hospital

DanielJonMerensteinMD

Family Medicine Vienna, VA

Hospital Medicine/Hospitalist

Associate Professor, Family Medicine, Georgetown University School of Medicine

Are you Dr. Merenstein?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 89 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Daniel Merenstein, MD is a board certified family physician in Vienna, Virginia. He is currently licensed to practice medicine in Virginia, Massachusetts, and Maryland. He is affiliated with Inova Fairfax Medical Campus, MedStar Georgetown University Hospital, and Inova Loudoun Hospital.

Education & Training

  • Inova Fairfax Medical Campus
    Inova Fairfax Medical CampusResidency, Family Medicine, 1997 - 2000
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1998 - 2026
  • MD State Medical License
    MD State Medical License 2010 - 2025
  • DC State Medical License
    DC State Medical License 2001 - 2024
  • MA State Medical License
    MA State Medical License 2010 - 2021
  • American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • What Are 'Antibiotic Diets'?
    What Are 'Antibiotic Diets'?March 16th, 2022
  • Probiotic-Containing Yogurt May Protect Against Gut Microbiome Changes Linked to Antibiotics
    Probiotic-Containing Yogurt May Protect Against Gut Microbiome Changes Linked to AntibioticsSeptember 22nd, 2021
  • A Genomic Variant of ALPK2 Is Associated with Increased Liver Fibrosis Risk in HIV/HCV Coinfected Women
    A Genomic Variant of ALPK2 Is Associated with Increased Liver Fibrosis Risk in HIV/HCV Coinfected WomenMarch 11th, 2021
  • Join now to see all

Hospital Affiliations